Biochemical Validation of Patient-Reported Symptom Onset Time in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- 1 May 2015
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 8 (6) , 778-787
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion TherapyCirculation, 2014
- Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial InfarctionNew England Journal of Medicine, 2013
- Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarctionAmerican Heart Journal, 2012
- Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital MortalityJAMA, 2012
- Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays IncreaseCirculation, 2011
- Quantitative Analysis of the Impact of Total Ischemic Time on Myocardial Perfusion and Clinical Outcome in Patients With ST-Elevation Myocardial InfarctionThe American Journal of Cardiology, 2011
- System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary InterventionJAMA, 2010
- Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial InfarctionJACC, 2010
- Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial InfarctionCirculation, 2004
- Symptom presentation of acute myocardial infarction: Influence of sex, age, and risk factorsAmerican Heart Journal, 2002